Effectiveness of aspen bark extract (Populus tremula L.) as an interferon inducer in recurrent infections caused by herpes simplex virus types 1 and 2
- Authors: Sergun V.P.1, Burkova V.N.1, Ivanov A.A.1, Ponezheva Z.B.2
-
Affiliations:
- "Biolit" LLC
- FBIS Central Research Institute of Epidemiology of Rospotrebnadzor
- Issue: Vol 29, No 1 (2026)
- Pages: 51-58
- Section: Medical chemistry
- URL: https://journals.rcsi.science/1560-9596/article/view/375519
- DOI: https://doi.org/10.29296/25877313-2026-01-07
- EDN: https://elibrary.ru/XBQCAT
- ID: 375519
Cite item
Abstract
Introduction. Herpesvirus infections are among the most common viral infections. The scale of their incidence and the psychological and physiological damage they cause determine the significant medical and social significance of herpesvirus infections.
Work Objective is a study of the effectiveness and safety of using a dietary supplement based on aspen bark extract as an interferon inducer in recurrent infections caused by herpes simplex virus types 1 and 2.
Material and methods. The object of the study was a «Populin» – biologically active food supplement based on a concentrated aqueous extract of aspen bark (Populus tremula L.). The observation included patients with diagnosed recurrent infection caused by herpes simplex virus types 1 and 2. The patients were matched in age and gender. During the study, tolerability and possible adverse events were recorded and vital signs were monitored. The interferon status of patients was analyzed by determining the amount of interferons alpha and gamma, as well as the induced production of these interferons by blood leukocytes in the comparison groups in dynamics.
Results. It has been found out that the use of aspen bark extract reduced the amount of herpes infection relapses – 70.6% of patients noted clinical improvement. The use of aspen bark extract contributed to positive clinical dynamics by reducing the area of damage and the number of rashes – their share has decreased in 6 times. Aspen bark extract normalized disturbances in the interferon status of patients – it reduced interferon deficiency of varying severity. Statistically significant changes in the dynamics of production of induced interferons alpha and gamma were noted.
Conclusions. As a result of the studies, it has been found out that the use of a biologically active food supplement «Populin» based on aspen bark extract bark in patients with recurrent herpesvirus infection caused by the herpes simplex virus types 1 and 2 helps to reduce the frequency of relapses, the area of damage and the severity of clinical symptoms, and stabilizes the interferon status of patients by normalizing the production of induced interferons alpha and gamma.
About the authors
V. P. Sergun
"Biolit" LLC
Author for correspondence.
Email: infobiolit@yandex.ru
ORCID iD: 0009-0003-6368-9992
SPIN-code: 7538-0687
Ph.D. (Chem.), Director, Assistant of the Department of Agronomy and Technology of Production and Processing of Agricultural Products
Russian Federation, 4 bilding 3, Akademichesky Ave, Tomsk, 634055V. N. Burkova
"Biolit" LLC
Email: infobiolit@yandex.ru
ORCID iD: 0009-0003-4253-4764
SPIN-code: 1528-7636
Dr.Sc. (Chem.), Director of Science and Innovation
Russian Federation, 4 bilding 3, Akademichesky Ave, Tomsk, 634055A. A. Ivanov
"Biolit" LLC
Email: infobiolit@yandex.ru
ORCID iD: 0009-0004-4321-388X
SPIN-code: 8478-9107
Ph.D. (Chem.), Head of Research Department
Russian Federation, 4 bilding 3, Akademichesky Ave, Tomsk, 634055Zh. B. Ponezheva
FBIS Central Research Institute of Epidemiology of Rospotrebnadzor
Email: infobiolit@yandex.ru
ORCID iD: 0000-0002-6539-4878
SPIN-code: 3035-5381
Dr.Sc. (Med.), Head of the Clinical Department of Infectious Pathology
Russian Federation, 3a Novogireevskaya st., Moscow, 111123References
- Letyaeva O.I., Ziganshin O.R., Kudrevich Yu.V. et al. Genital herpes: a modern concept of therapy. Russkiy meditsinskiy zhurnal. 2015; 28: 1701–1704. (In Russ.).
- Malkin J.E. Epidemiology of genital herpes simplex virus infection in developed countries. Herpes. 2004; 11(1): 2A–23A.
- World Health Organization. Herpes simplex virus. Fact sheets (Cited 13 Sept. 2024). [Internet]. Available from: https://www.who.int/ru/news-room/fact-sheets/detail/herpes-simplex-virus.
- Ma Y., Verpooten D, He B. Herpes Simplex Viruses and Induction of Interferon Responses. Virologica Sinica. 2008; 23(6): 416–428. doi: 10.1007/s12250-008-2999-7.
- Danastas K., Guo G., Merjane J. et al. Interferon inhibits the release of herpes simplex virus-1 from the axons of sensory neurons. mBio. 2023; 14(5): e01818–23. doi: 10.1128/mbio.01818-23.
- Danastas K., Miranda-Saksena M., Cunningham A.L. Herpes Simplex Virus Type 1 Interactions with the Interferon System. International Journal of Molecular Sciences. 2020; 21(14): 5150. doi: 10.3390/ijms21145150.
- Sologub T.V., Golobokov G.S., Tsvetkov V.V. et al. Interferon-gamma in the treatment of influenza and other respiratory viral infections. Meditsinskiy Sovet. 2015; (7): 54–58. (In Russ.). doi: 10.21518/2079-701X-2015-7-54-58.
- Berhardt L.V (ed). Advances in Medicine & Biology: Volume 124. New York: Nova Science Publishers Inc.; 2017.
- Gizinger O.A., Shemetova M.A., Ziganshin O.R. Validity of the use of interferon therapy in the treatment of herpesvirus infection in dermatovenereological practice. Lechashchiy vrach. 2016; 5: 101–105. (In Russ.).
- Khryanin A.A., Reshetnikov O.V. Interferon inductors in therapy for genital herpes in women. Akusherstvo i ginekologiya. 2015; 7: 88–93. (In Russ.).
- Burkova V.N., Ivanov A.A., Sergun V.P. Aspen (Populus tremula L.) in evidence-based medicine of the XXI century. Tomsk: Izdatel'stvo «Krasnoye znamya»; 2020. (In Russ.).
- Burkova V.N., Bychkova N.K., Strelis A.K. et al. Anti-tuberculosis activity of aspen bark extract (experimental study). Byulleten' sibirskoy meditsiny. 2006; 2: 49–51. (In Russ.).
- Makashova V.V., Ponezheva Zh.B., Omarova H.G. et al. Experience of using Populin with dihydroquercetin in new coronavirus infection. Epidemiologiya i infektsionnyye bolezni. Aktual'nyye voprosy. 2022; 2: 77–82. (In Russ.). doi: 10.18565/epidem.2022.12.2.77-82.
- GOST R 52379-2005. Good Clinical Practice (GCP). Introduced on 2006-04-01. Moscow. 2005. 38 p. (In Russ.).
- Burtis C.A., Ashwood E.R., Bruns D.E. (eds). Tietz Textbook of Clinical Chemistry and Molecular Diagnosis (5th edition). St. Louis: Elsevier; 2012.
Supplementary files
